Testim, which delivered sales of $211.2 million last year, is under significant pressure with the product expected to post revenues of less than $85 million this year. Challenges being faced by Testim ...

Specialty biopharmaceutical company, Auxilium Pharmaceuticals, Inc. (AUXL) recently entered into a co-promotion agreement with GlaxoSmithKline plc's (GSK) U.S. subsidiary, GlaxoSmithKline LLC. The ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Tricentis, a software test automation ...

The article by Grober et al. 1 provides valuable clinical information regarding the two Food and Drug Administration-approved formulations of testosterone (T) gels, Androgel and Testim. The authors ...

"While Testim has continued to represent an important portion of Auxilium's net sales, we have been proactively planning for this launch in an effort to most strategically position our product ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

Automated software testing platform Testim has raised $10 million in a series B round of funding led by SignalFire, with participation from Lightspeed Venture Partners, Meron Capital, NHN Ventures, ...

The ongoing class action lawsuit against several makers of testosterone medications hasn’t been going well for AbbVie—it has lost two cases so far—but the legal saga is playing out quite differently ...

Hypogonadism is common and increases with age in men as serum testosterone levels gradually decline. Estimates of the prevalence of androgen deficiency among men 40–70 years of age range from 12 to 45 ...